Both in Pharmaceuticals
Serina Therapeutics vs SCYNEXIS
Over the past year SER returned −62.7% and SCYX returned −19.8%; their daily moves had a correlation of -0.02.
SER −62.7% SCYX −19.8%Growth of $1, one year, split-adjusted
| Metric | SER | SCYX |
|---|---|---|
| Price | $2.00 | $4.94 |
| Market cap | $50.8M | $49.2M |
| Today | −3.85% | +6.01% |
| 1 month | −17.4% | −5.5% |
| 6 months | +3.1% | −32.7% |
| Year to date | +4.5% | −2.4% |
| 1 year | −59.1% | −41.2% |
| Revenue growth (YoY) | −100.0% | −82.8% |
| Gross margin | — | 100.0% |
| Net margin | — | 3147.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.6× |
| Net cash | $19.9M | $54.1M |
| Dividend yield | — | — |
| Volatility (60d) | 76.5% | 86.4% |
| Short % of float | 1.7% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).